EP1.14-43 The Safety of First-line and Subsequent Monotherapy of PD-1/PD-L1 Inhibitors in NSCLC: A Meta Analysis

Y. Yang,Z. Xie, P. Pang, N. Wang,H. Liang, L. Zhao

JOURNAL OF THORACIC ONCOLOGY(2019)

引用 0|浏览25
暂无评分
关键词
NSCLC,PD-1/PD-L1 inhibitors,treatment related adverse events
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要